 | Up a level |
Ranganath, LR, Milan, AM, Hughes, AT, Davison, AS 
ORCID: 0000-0001-5501-4475, Khedr, M, Norman, BP ORCID: 0000-0001-9293-4852, Bou-Gharios, G, Gallagher, JA ORCID: 0000-0002-0852-279X, Gornall, M, Jackson, R et al (show 4 more authors)
(2022)
Characterization of changes in the tyrosine pathway by 24-h profiling during nitisinone treatment in alkaptonuria.
Molecular Genetics and Metabolism Reports, 30.
p. 100846.
Ranganath, LR, Milan, AM, Hughes, AT, Davison, AS, Khedr, M, Norman, BP, Bou-Gharios, G, Gallagher, JA, Imrich, R, Arnoux, JB et al (show 2 more authors)
(2022)
Determinants of tyrosinaemia during nitisinone therapy in alkaptonuria.
SCIENTIFIC REPORTS, 12 (1).
16083-.
Braconi, D, Giustarini, D, Marzocchi, B, Peruzzi, L, Margollicci, M, Rossi, R, Bernardini, G, Millucci, L, Gallagher, JA ORCID: 0000-0002-0852-279X, Sang, K-H Le Quan et al (show 5 more authors)
(2018)
Inflammatory and oxidative stress biomarkers in alkaptonuria: data from the DevelopAKUre project.
OSTEOARTHRITIS AND CARTILAGE, 26 (8).
pp. 1078-1086.
Ranganath, LR, Hughes, AT, Davison, AS, Khedr, M, Olsson, B, Rudebeck, M, Imrich, R, Norman, BP ORCID: 0000-0001-9293-4852, Bou-Gharios, G, Gallagher, JA ORCID: 0000-0002-0852-279X et al (show 1 more authors)
(2022)
Temporal adaptations in the phenylalanine/tyrosine pathway and related factors during nitisinone-induced tyrosinaemia in alkaptonuria.
Molecular genetics and metabolism.
S1096-7192(22)00325-0-.